The MOZART® Specimen tomosynthesis Imaging System has been shown to dramatically improve surgeons’ and facilities’ re-excision rate, the rate at which second surgeries need to be performed following a lumpectomy due to positive margins for cancer cells.

The MOZART System is a state-of-the art technology that enables the surgeon to visualize the tumor right in the operating room, which no other technology or technique allows. The technology provides clear images of targeted lesions in the specimen, even through obstructions like dense tissue or skin. It creates true 3D images of breast specimens in 1 mm slices during the operation, which enables surgeons to identify the exact location, character, and extent of lesions three-dimensionally. The ability to more accurately confirm the extent of the target excision helps surgeons perform more precise procedures and minimize removal of healthy tissue.

Surgeons using the MOZART system during lumpectomy procedures have reported their re-excision rate, or the rate that patients need to return for a second surgery due to positive margins cells, has dropped substantially. The nationally accepted re-excision rate following lumpectomies is 20%, meaning one in five patients will need a second surgery, which can be traumatic and costly. Using the MOZART in the operating room has helped surgeons reduce this rate to around 5%.

The MOZART System also saves time in the operating room because the surgeon does not have to wait while a specimen is taken to a separate radiology area for analysis. Studies show that using the MOZART System during surgery can reduce a lumpectomy procedure by as much as 15 minutes, which for a patient means less time under anesthesia.

This capability has taken on greater significance during the COVID-19 pandemic where the ability to limit repeat surgeries and increase operating room efficiency has been recognized as important to promoting a safer environment for patient and clinical care team, alike.